Presented by AstraZeneca{beacon} Health Care Health Care   The Big Story PEPFAR survives rescissions Senate Republicans are removing a global anti-HIV program from the White

The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with Trump administration priorities, but will apparently leave one critical public health program alone.

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their efforts to fight HIV infections – especially for groups most at risk and in areas where the burden of HIV remains high.

PEPFAR, the U.S. President’s Emergency Plan for AIDS Relief, has been hailed as “the most important and consequential contribution to public health”,